Randomized Assessment of Rapid Endovascular Treatment of Ischemic.pdf (257.92 kB)
Download file

Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke.

Download (257.92 kB)
journal contribution
posted on 2022-03-08, 15:15 authored by Mayank Goyal, Andrew M. Demchuk, Bijoy K. Menon, Muneer Eesa, Jeremy L. Rempel, John Thornton, Daniel Roy, Tudor G. Jovin, Robert A Willinsky, Biggya L. Sapkota, Dar Dowlatshahi, Donald F. Frei, Noreen R. Kamal, Walter J. Montanera, Alexandre Y. Poppe, Karla J. Ryckborst, Frank L. Silver, Ashfaq Shuaib, Donatella Tampieri, David WilliamsDavid Williams, Oh Young Bang, Blaise W. Baxter, Paul A. Burns, Hana Choe, Ji-Hoe Heo, Christine A. Holmstedt, Brian Jankowitz, Michael Kelly, Guillermo Linares, Jennifer L. Mandzia, Jai Shankar, Sung-Il Sohn, Richard H. Swartz, Philip A. Barber, Shelagh B. Coutts, Eric E. Smith, William F. Morrish, Alain Weill, Suresh Subramaniam, Alim P. Mitha, John H. Wong, Mark W. Lowerison, Tolulope T. Sajobi, Michael D. Hill

Background Among patients with a proximal vessel occlusion in the anterior circulation, 60 to 80% of patients die within 90 days after stroke onset or do not regain functional independence despite alteplase treatment. We evaluated rapid endovascular treatment in addition to standard care in patients with acute ischemic stroke with a small infarct core, a proximal intracranial arterial occlusion, and moderate-to-good collateral circulation.

Methods We randomly assigned participants to receive standard care (control group) or standard care plus endovascular treatment with the use of available thrombectomy devices (intervention group). Patients with a proximal intracranial occlusion in the anterior circulation were included up to 12 hours after symptom onset. Patients with a large infarct core or poor collateral circulation on computed tomography (CT) and CT angiography were excluded. Workflow times were measured against predetermined targets. The primary outcome was the score on the modified Rankin scale (range, 0 [no symptoms] to 6 [death]) at 90 days. A proportional odds model was used to calculate the common odds ratio as a measure of the likelihood that the intervention would lead to lower scores on the modified Rankin scale than would control care (shift analysis).

Results The trial was stopped early because of efficacy. At 22 centers worldwide, 316 participants were enrolled, of whom 238 received intravenous alteplase (120 in the intervention group and 118 in the control group). In the intervention group, the median time from study CT of the head to first reperfusion was 84 minutes. The rate of functional independence (90-day modified Rankin score of 0 to 2) was increased with the intervention (53.0%, vs. 29.3% in the control group; P


The Heart and Stroke Foundation of Canada, Alberta Innovates-Health Solutions and Medtronic, HBI Stroke Team, Calgary Stroke Program



The original article is available at http://www.nejm.org/doi/full/10.1056/NEJMoa1414905

Published Citation

Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, Roy D, Jovin TG, Willinsky RA, Sapkota BL, Dowlatshahi D, Frei DF, Kamal NR, Montanera WJ, Poppe AY, Ryckborst KJ, Silver FL, Shuaib A, Tampieri D, Williams D, Bang OY, Baxter BW, Burns PA, Choe H, Heo JH, Holmstedt CA, Jankowitz B, Kelly M, Linares G, Mandzia JL, Shankar J, Sohn SI, Swartz RH, Barber PA, Coutts SB, Smith EE, Morrish WF, Weill A, Subramaniam S, Mitha AP, Wong JH, Lowerison MW, Sajobi TT, Hill MD; the ESCAPE Trial Investigators. Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke. New England Journal of Medicine. 2015;372(11):1019-30

Publication Date


PubMed ID



  • Beaumont Hospital
  • Medicine